American International Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,664
| Closed | -$205K | – | 2593 |
|
|
2024
Q1 | $205K | Buy |
13,664
+143
| +1% | +$2.15K | ﹤0.01% | 2137 |
|
|
2023
Q4 | $203K | Buy |
13,521
+3,756
| +38% | +$56.3K | ﹤0.01% | 2167 |
|
|
2023
Q3 | $137K | Buy |
9,765
+348
| +4% | +$4.88K | ﹤0.01% | 2336 |
|
|
2023
Q2 | $97.5K | Buy |
+9,417
| New | +$97.5K | ﹤0.01% | 2591 |
|
|
2022
Q2 | – | Sell |
-9,685
| Closed | -$84K | – | 3268 |
|
|
2022
Q1 | $84K | Sell |
9,685
-682
| -7% | -$5.92K | ﹤0.01% | 2658 |
|
|
2021
Q4 | $99K | Sell |
10,367
-309
| -3% | -$2.95K | ﹤0.01% | 2723 |
|
|
2021
Q3 | $180K | Sell |
10,676
-254
| -2% | -$4.28K | ﹤0.01% | 2489 |
|
|
2021
Q2 | $167 | Sell |
10,930
-366
| -3% | -$6 | ﹤0.01% | 2624 |
|
|
2021
Q1 | $220 | Buy |
11,296
+29
| +0.3% | +$1 | ﹤0.01% | 2320 |
|
|
2020
Q4 | $203 | Sell |
11,267
-324
| -3% | -$6 | ﹤0.01% | 2283 |
|
|
2020
Q3 | $224K | Sell |
11,591
-262
| -2% | -$5.06K | ﹤0.01% | 2079 |
|
|
2020
Q2 | $310K | Buy |
11,853
+762
| +7% | +$19.9K | ﹤0.01% | 1854 |
|
|
2020
Q1 | $198K | Sell |
11,091
-642
| -5% | -$11.5K | ﹤0.01% | 1910 |
|
|
2019
Q4 | $392K | Sell |
11,733
-98
| -0.8% | -$3.27K | ﹤0.01% | 1832 |
|
|
2019
Q3 | $282K | Sell |
11,831
-82
| -0.7% | -$1.96K | ﹤0.01% | 1974 |
|
|
2019
Q2 | $428K | Buy |
+11,913
| New | +$428K | ﹤0.01% | 1786 |
|